MaxCyte
(NASDAQ) MXCT
MaxCyte Financials at a Glance
Market Cap
$92.24M
Revenue (TTM)
$33.03M
Net Income (TTM)
$44.63M
EPS (TTM)
$-0.42
P/E Ratio
-2.06
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.86
Volume
5,495
Open
$0.83
Price
$0.86
Volume
5,495
Open
$0.83
Previous Close
$0.86
Daily Range
$0.83 - $0.87
52-Week Range
$0.64 - $2.96
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.86
Volume
5,495
Open
$0.83
Previous Close
$0.86
Daily Range
$0.83 - $0.87
52-Week Range
$0.64 - $2.96
MXCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MaxCyte
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
91
CEO
Maher Masoud
Website
www.maxcyte.comHeadquarters
Rockville, MD 20850, US
MXCT Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-24%
Return on Capital
-23%
Return on Assets
-22%
Earnings Yield
-48.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$92.24M
Shares Outstanding
106.86M
Volume
5.50K
Short Interest
0.00%
Avg. Volume
1.15M
Financials (TTM)
Gross Profit
$22.58M
Operating Income
$43.55M
EBITDA
$38.40M
Operating Cash Flow
$34.41M
Capital Expenditure
$1.77M
Free Cash Flow
$36.18M
Cash & ST Invst.
$103.04M
Total Debt
$17.94M
MaxCyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.30M
-16.0%
Gross Profit
$384.00K
-94.0%
Gross Margin
5.26%
N/A
Market Cap
$92.24M
N/A
Market Cap/Employee
$809.14K
N/A
Employees
114
N/A
Net Income
$9.60M
+9.4%
EBITDA
$5.40M
+52.5%
Quarterly Fundamentals
Net Cash
$85.10M
-37.6%
Accounts Receivable
$3.50M
-25.2%
Inventory
$7.55M
-15.3%
Long Term Debt
$16.49M
-4.0%
Short Term Debt
$1.46M
+68.5%
Return on Assets
-22.04%
N/A
Return on Invested Capital
-23.13%
N/A
Free Cash Flow
$2.92M
+63.4%
Operating Cash Flow
$2.69M
+65.6%